van Haren, Frank M. P. http://orcid.org/0000-0001-8037-4229
Page, Clive
Laffey, John G.
Artigas, Antonio
Camprubi-Rimblas, Marta
Nunes, Quentin
Smith, Roger
Shute, Janis
Carroll, Mary
Tree, Julia
Carroll, Miles
Singh, Dave
Wilkinson, Tom
Dixon, Barry
Article History
Received: 16 June 2020
Accepted: 3 July 2020
First Online: 22 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: FvH, CP, JL, QN, RS, BD, JT and MC have nothing to disclose. TW is Chief Investigator of the ACCORD COVID Research Programme. AA and MCR report grants from Grifols, outside the submitted work. JS is the Scientific Director of Ockham Biotech Ltd., a company that owns patents around the use of inhaled heparin. DS reports personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Chiesi, personal fees from Cipla, personal fees from Genentech, personal fees from GlaxoSmithKline, personal fees from Glenmark, personal fees from Gossamerbio, personal fees from Menarini, personal fees from Mundipharma, personal fees from Novartis, personal fees from Peptinnovate, personal fees from Pfizer, personal fees from Pulmatrix, personal fees from Theravance and personal fees from Verona, outside the submitted work.